These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 13549575)

  • 1. Biochemical and clinical changes resulting from administration of marsilid and tryptophan to schizophrenic patients; the clinical aspects.
    LAUER JW
    J Clin Exp Psychopathol; 1958; 19(2, Suppl. 1):110-3. PubMed ID: 13549575
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical and clinical changes resulting from administration of marsilid and tryptophan to schizophrenic patients; biochemical aspects.
    ZELLER EA
    J Clin Exp Psychopathol; 1958; 19(2, Suppl. 1):106-9. PubMed ID: 13549574
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biochemical and physiopathological bases of the study of tryptophan metabolism in schizophrenia].
    Dogaru C; Grecu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1984; 29(2):141-50. PubMed ID: 6238390
    [No Abstract]   [Full Text] [Related]  

  • 4. [Disturbances of tryptophan metabolism during methionine and nialamide administration in chronic schizophrenic patients].
    Rosengarten H; Stencka K; Kowalska K; Wardaszko-Lyskowska H; Szemis A; Wlosińska I; Krzyzowski J; Jus A
    Psychiatr Pol; 1970; 4(3):261-8. PubMed ID: 5459695
    [No Abstract]   [Full Text] [Related]  

  • 5. Tryptophan-nicotinic acid metabolism in schizophrenia.
    BANERJEE S; AGARWAL PS
    Proc Soc Exp Biol Med; 1958 Mar; 97(3):657-9. PubMed ID: 13518366
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tryptophan and its metabolism in schizophrenia].
    Szafranek J; Szafranek K
    Psychiatr Pol; 1970; 4(5):585-8. PubMed ID: 4921675
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tryptophan-nicotinic acid metabolism in psychiatric diseases].
    Chiancone FM
    Acta Vitaminol Enzymol; 1968; 22(3):111-33. PubMed ID: 4239848
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical aspects of schizophrenia.
    Stewart BM
    Am J Nurs; 1975 Dec; 75(12):2176-9. PubMed ID: 53014
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies in schizophrenia, V. Disturbances of protein and tryptophan metabolism and toxicity of urine.
    FLEISCHHACKER HH; LANCASTER JB; WHEELER AP
    J Ment Sci; 1959 Apr; 105(439):313-25. PubMed ID: 13665293
    [No Abstract]   [Full Text] [Related]  

  • 10. Schizophrenia, a disorder of tryptophan metabolism.
    Gilka L
    Acta Psychiatr Scand Suppl; 1975; 258():1-83. PubMed ID: 1056684
    [No Abstract]   [Full Text] [Related]  

  • 11. [Correlation between disturbances of tryptophan metabolism induced by methionine and nialamide administration and changes of the mental state in chronic schizophrenic patients].
    Jus A; Rosengarten H; Wardaszko-Lyskowska H; Szemis A; Stencka K; Wlosińska I; Krzyzowski J; Kowalska K
    Psychiatr Pol; 1970; 4(4):365-71. PubMed ID: 5472573
    [No Abstract]   [Full Text] [Related]  

  • 12. Disturbances in tryptophan and serotonin metabolism in affective psychoses and schizophrenia.
    Puzyński S; Jakomow B
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):47-60. PubMed ID: 1107970
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tryptophan metabolism in schizophrenia].
    Rosengarten H; Marcjan K; Cwiertnia T; Stencka K; Rybus G
    Psychiatr Pol; 1970; 4(3):253-9. PubMed ID: 5459694
    [No Abstract]   [Full Text] [Related]  

  • 14. [Research into the biochemical bases of schizophrenic syndromes: a review].
    Laplante M; St-Laurent J
    Union Med Can; 1973 Nov; 102(11):2267-78. PubMed ID: 4134633
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytokine changes and tryptophan metabolites in medication-naïve and medication-free schizophrenic patients.
    Kim YK; Myint AM; Verkerk R; Scharpe S; Steinbusch H; Leonard B
    Neuropsychobiology; 2009; 59(2):123-9. PubMed ID: 19390223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methionine and tryptophan loading in schizophrenic patients receiving a MAO inhibitor: correlation of behavioral and biochemical changes.
    Spaide J; Neveln L; Tolentino J; Himwich HE
    Biol Psychiatry; 1969 Jul; 1(3):227-33. PubMed ID: 5352654
    [No Abstract]   [Full Text] [Related]  

  • 17. Validity of plasma factor in schizophrenia as measured by tryptophan uptake.
    Guchhait RB; Janson C; Price WH
    Biol Psychiatry; 1975 Jun; 10(3):303-14. PubMed ID: 49200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenia, rheumatoid arthritis and trytophan metabolism.
    Taylor WM
    J Clin Psychiatry; 1978 Jun; 39(6):499-503. PubMed ID: 659373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities in tryptophan metabolites in schizophrenia.
    Frohman CE; Caldwell DF; Gottlieb JS
    Psychopharmacol Bull; 1974 Jul; 10(3):56-7. PubMed ID: 4473060
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients.
    Myint AM; Schwarz MJ; Verkerk R; Mueller HH; Zach J; Scharpé S; Steinbusch HW; Leonard BE; Kim YK
    Brain Behav Immun; 2011 Nov; 25(8):1576-81. PubMed ID: 21620952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.